Sierra Oncology Inc

Market cap: $

Exchange: NAS

Sector: Health Technology

Sierra Oncology, Inc. is a clinical stage drug development company of therapeutics for the treatment of cancer. The firm focuses on advancing targeted therapeutics for the treatment of patients with significant unmet medical needs in hematology and oncology. Its product Momelotinib, a selective and orally-bioavailable JAK1, JAK2 & ACVR1 inhibitor with a differentiated therapeutic profile in myelofibrosis encompassing robust constitutional symptom improvements. The company was founded on May 8, 2003 and is headquartered in Vancouver, Canada.

STOCK PRICE CHART

Key Statistics

Company Name

Sierra Oncology Inc

Average Volume (10 days)

Average Volume (30 days)

Moving Average (50 days)

Moving Average (200 days)

Ex-Divided Date

n/a

Dividend Yield

P/E Ratio

Market Cap

Shares Outstanding

24,419,349

52-Week High Split Adjust Only

52-Week Low Split Adjust Only

Employee Count

Beta

Next Earnings Date

TTM Dividend Rate Per Share

Price Changes

Past 5 days

Past 30 days

Past 3 months

Past 6 months

Past year

Past 2 years

Past 5 years

Max % Change

PEER GROUP COMPARATIVE PERFORMANCE

Name	Ticker	Price/Sales (ttm)	Price/Book (ttm)	Forward P/E	PEG Ratio	EV/Revenue
Sierra Oncology Inc	SRRA	n/a	n/a	-2.7	n/a	n/a
Peer Avg	N/A	1.09	1.08	-0.7	1.09	1.26
Novartis AG - ADR	NVS	4.37	4.32	n/a	4.37	5.05
Ocuphire Pharma Inc	OCUP	n/a	n/a	-2.9	n/a	n/a